Highlights
Revenue from ordinary activities increased considerably during the period to US$5,5526,000. This
marks an 80% increase on the previous corresponding period (CY 2018: US$3,062,000).
Yimei was successful in obtaining Chinese software copyright registration for the Prizma
smartphone app, and subsequently the Chinese version of the Prizma Android app was released
to the Tencent App Stock, meaning the Prizma iOS app is ready for release on the China Apple
store. Further, Yimei commenced designs for a medical smartwatch and software requirement
analysis is also underway for blood pressure measurement.
Yimei also showcased at a number of exhibits and events ahead of the launch of the Prizma device
in the People’s Republic of China. These showcases coincided with a multi-faceted marketing
approach purposefully designed for specific territories.
Risks
IMO - delays on approval due to Corona taking NMPA staffing for other activities.
- Forums
- ASX - By Stock
- GMV
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-2
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)